| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005141427 |
| P356 | DOI | 10.1186/1471-2407-10-166 |
| P8608 | Fatcat ID | release_lomejwity5h7zbp2endk57zosi |
| P932 | PMC publication ID | 2868812 |
| P698 | PubMed publication ID | 20426848 |
| P5875 | ResearchGate publication ID | 43350926 |
| P50 | author | Adrian Biddle | Q59698379 |
| P2093 | author name string | Daniela Elena Costea | |
| Ian C Mackenzie | |||
| Lisa J Harper | |||
| Bilal Fazil | |||
| Luke Gammon | |||
| P2860 | cites work | EpCAM (CD326) finding its role in cancer | Q24653692 |
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
| A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 | ||
| Identification of selective inhibitors of cancer stem cells by high-throughput screening | Q28255115 | ||
| Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells | Q28264780 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells | Q28294874 | ||
| Prospective identification of tumorigenic prostate cancer stem cells | Q29547859 | ||
| Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma | Q29615607 | ||
| Tumour stem cells and drug resistance | Q29617742 | ||
| Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
| The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation | Q29620694 | ||
| Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties | Q29636244 | ||
| Stem cell origin of cancer and differentiation therapy | Q33203952 | ||
| Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma | Q33303046 | ||
| Intestinal stem cells protect their genome by selective segregation of template DNA strands. | Q34128111 | ||
| Colonization of adjacent stem cell compartments by mutant keratinocytes. | Q34384610 | ||
| Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s | Q34588433 | ||
| Therapeutic implications of cancer stem cells. | Q35756019 | ||
| Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia | Q36123682 | ||
| Cancer stem cells and oncology therapeutics | Q36667691 | ||
| Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy | Q36678657 | ||
| Cancer stem cells in solid tumors | Q37006419 | ||
| Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma | Q37414399 | ||
| Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation | Q38186098 | ||
| Trends in oral cancer mortality in Europe | Q38480167 | ||
| PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells | Q40002554 | ||
| Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells | Q40105497 | ||
| Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer | Q40254662 | ||
| Aberrant activation of notch signaling in human breast cancer | Q40322042 | ||
| Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. | Q40365745 | ||
| EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway | Q40405623 | ||
| Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis. | Q42502020 | ||
| Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries | Q43596226 | ||
| A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy | Q45880611 | ||
| Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli | Q46426199 | ||
| The in vitro behaviour and patterns of colony formation of murine epithelial stem cells. | Q53526974 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 166 | |
| P577 | publication date | 2010-04-28 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance | |
| P478 | volume | 10 |
| Q107113532 | Ca1 |
| Q107113534 | CalH2 |
| Q107113535 | CalH3 |
| Q54872075 | H357 |
| Q107117204 | UK1 |
| Q107117256 | UM-SCC-5PT |
| Q39036241 | ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. |
| Q33596683 | Altered cell cycle regulation helps stem-like carcinoma cells resist apoptosis |
| Q57037685 | Aneuploidy in intestinal stem cells promotes gut dysplasia in |
| Q34770470 | Anoikis mediators in oral squamous cell carcinoma |
| Q57821304 | Basal Cell Carcinoma Arises from Interfollicular Layer of Epidermis |
| Q35221037 | Biological responses of three-dimensional cultured fibroblasts by sustained compressive loading include apoptosis and survival activity |
| Q37839530 | Breast cancer stem cells: treatment resistance and therapeutic opportunities |
| Q39467150 | CD44 is a biomarker associated with human prostate cancer radiation sensitivity |
| Q39582112 | CD44 is associated with proliferation, rather than a specific cancer stem cell population, in cultured canine cancer cells |
| Q45406868 | CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma |
| Q39817310 | Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma |
| Q47130831 | Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state. |
| Q43653286 | Cancer stem cell immunophenotypes in oral squamous cell carcinoma |
| Q42006656 | Cancer stem cell markers in head and neck squamous cell carcinoma. |
| Q37981073 | Cancer stem cells and EMT in carcinoma. |
| Q28081844 | Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? |
| Q38908575 | Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. |
| Q39814561 | Cell division patterns and chromosomal segregation defects in oral cancer stem cells |
| Q58094206 | Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention |
| Q39104687 | Co-expression of CD44+/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma |
| Q49059298 | Comparison of bulbar and mucosal olfactory ensheathing cells using FACS and simultaneous antigenic bivariate cell cycle analysis |
| Q38961918 | Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors. |
| Q35918956 | Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells. |
| Q39433158 | Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy |
| Q36786443 | FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition |
| Q38287518 | Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target. |
| Q39012204 | Human oral cancer cells with increasing tumorigenic abilities exhibit higher effective membrane capacitance |
| Q36910062 | Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer |
| Q37588083 | Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells |
| Q46023053 | Intestinal stem cell ablation reveals differential requirements for survival in response to chemical challenge. |
| Q36685543 | Invasive oral cancer stem cells display resistance to ionising radiation. |
| Q45332975 | Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells? |
| Q34459980 | Isolation and genomic characterization of stem cells in head and neck cancer. |
| Q38635079 | Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle |
| Q90216421 | Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance |
| Q26766613 | Organic Nanomaterials and Their Applications in the Treatment of Oral Diseases |
| Q47834312 | Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype |
| Q38373387 | Postembryonic Fish Brain Proliferation Zones Exhibit Neuroepithelial-Type Gene Expression Profile |
| Q54323098 | Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase. |
| Q39562499 | Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells |
| Q39463009 | Slow-cycling therapy-resistant cancer cells |
| Q39622929 | Stem cell characteristics of cell sub-populations in cell lines derived from head and neck cancers of Fanconi anemia patients |
| Q37844455 | Stem cells in tooth tissue regeneration--challenges and limitations |
| Q34701603 | Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. |
| Q31137385 | The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression |
| Q46553742 | The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma |
| Q39158710 | The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines. |
| Q36557422 | The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells |
| Q38957401 | The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells. |
| Q38339732 | The potential of CD44 as a diagnostic and prognostic tool in oral cancer |
| Q39093124 | The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma |
| Q37137412 | Therapeutic approaches to target cancer stem cells |
Search more.